CM-7919
CM-7919 is a next-generation cancer drug which has a wide spectrum of pipeline and is highly safe compared to other existing cancer drugs. Its active ingredient, As406, is an innovate substance which induce pyroptotic and apoptotic cell death on cancer cells. Cell tests and preclinical studies showed As4O6 works on glioblastoma(one of the most malignant brain tumors), TNBC cells, cervical cancer, pancreatic cancer, bladder cancer and more. Now with P1 clinical trials successfully complete at Asan Medical Hospital and all necessary preclinical studies carried out, CM-7919 anti-cancer drug project is preparing for the next phase clinical trial.